Combined analysis of keratinocyte cancers identifies novel genome-wide loci.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
15 09 2019
Historique:
received: 14 03 2019
revised: 30 05 2019
accepted: 03 06 2019
pubmed: 8 6 2019
medline: 10 3 2020
entrez: 8 6 2019
Statut: ppublish

Résumé

The keratinocyte cancers (KC), basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common cancers in fair-skinned people. KC treatment represents the second highest cancer healthcare expenditure in Australia. Increasing our understanding of the genetic architecture of KC may provide new avenues for prevention and treatment. We first conducted a series of genome-wide association studies (GWAS) of KC across three European ancestry datasets from Australia, Europe and USA, and used linkage disequilibrium (LD) Score regression (LDSC) to estimate their pairwise genetic correlations. We employed a multiple-trait approach to map genes across the combined set of KC GWAS (total N = 47 742 cases, 634 413 controls). We also performed meta-analyses of BCC and SCC separately to identify trait specific loci. We found substantial genetic correlations (generally 0.5-1) between BCC and SCC suggesting overlapping genetic risk variants. The multiple trait combined KC GWAS identified 63 independent genome-wide significant loci, 29 of which were novel. Individual separate meta-analyses of BCC and SCC identified an additional 13 novel loci not found in the combined KC analysis. Three new loci were implicated using gene-based tests. New loci included common variants in BRCA2 (distinct to known rare high penetrance cancer risk variants), and in CTLA4, a target of immunotherapy in melanoma. We found shared and trait specific genetic contributions to BCC and SCC. Considering both, we identified a total of 79 independent risk loci, 45 of which are novel.

Identifiants

pubmed: 31174203
pii: 5512167
doi: 10.1093/hmg/ddz121
pmc: PMC6737293
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3148-3160

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press.

Références

Nat Commun. 2015 Apr 09;6:6825
pubmed: 25855136
J Natl Cancer Inst. 2018 Sep 1;110(9):967-974
pubmed: 29767749
Hum Mol Genet. 2018 Mar 15;27(6):1122
pubmed: 29351605
Am J Hum Genet. 2011 Jan 7;88(1):76-82
pubmed: 21167468
Nucleic Acids Res. 2019 Jan 8;47(D1):D1056-D1065
pubmed: 30462303
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Cold Spring Harb Perspect Biol. 2010 Jan;2(1):a001008
pubmed: 20182602
BMC Med Ethics. 2016 Mar 31;17:19
pubmed: 27059184
Cancer Biol Ther. 2018 Aug 3;19(8):669-675
pubmed: 29580149
Nat Genet. 2008 Jul;40(7):838-40
pubmed: 18488026
Biomedicines. 2018 Jan 02;6(1):
pubmed: 29301290
Nat Genet. 2018 Nov;50(11):1593-1599
pubmed: 30349118
Oncotarget. 2017 Mar 14;8(11):17586-17592
pubmed: 28212542
Nat Commun. 2018 Oct 15;9(1):4264
pubmed: 30323283
Nat Genet. 2015 Mar;47(3):284-90
pubmed: 25642633
JAMA. 2016 Jan 5;315(1):68-76
pubmed: 26746459
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Am J Hum Genet. 2007 Nov;81(5):1084-97
pubmed: 17924348
Biopreserv Biobank. 2015 Oct;13(5):307-8
pubmed: 26484569
Nat Commun. 2018 May 8;9(1):1825
pubmed: 29739930
Genet Epidemiol. 2009 Jul;33(5):453-62
pubmed: 19140131
Nature. 2010 Oct 28;467(7319):1061-73
pubmed: 20981092
Dermatol Pract Concept. 2017 Apr 30;7(2):1-6
pubmed: 28515985
J Invest Dermatol. 2018 Mar;138(3):557-561
pubmed: 29054604
J Natl Cancer Inst. 2013 Jan 16;105(2):141-8
pubmed: 23257159
Nat Genet. 2011 Oct 09;43(11):1108-13
pubmed: 21983787
Oncotarget. 2016 May 31;7(22):32854-65
pubmed: 27147571
Genetics. 2018 Apr;208(4):1397-1408
pubmed: 29429966
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Nat Genet. 2015 Nov;47(11):1236-41
pubmed: 26414676
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Photodermatol Photoimmunol Photomed. 1996 Jun;12(3):95-9
pubmed: 8956357
Sci Transl Med. 2011 Apr 20;3(79):79re1
pubmed: 21508311
Aust N Z J Public Health. 2016 Apr;40(2):154-8
pubmed: 26558736
PLoS One. 2011;6(7):e20019
pubmed: 21760883
Br J Cancer. 2018 May;118(9):1262-1267
pubmed: 29581483
Sci Rep. 2016 Sep 08;6:32894
pubmed: 27604177
Am J Hum Genet. 2018 Dec 6;103(6):1053
pubmed: 30526863
Int J Epidemiol. 2012 Aug;41(4):929-929i
pubmed: 22933644
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Bioinformatics. 2015 Mar 1;31(5):782-4
pubmed: 25338720
J Immunol. 2000 Aug 15;165(4):1824-31
pubmed: 10925260
Biomedicines. 2017 Dec 20;5(4):
pubmed: 29261131
Nat Genet. 2016 Jul;48(7):811-6
pubmed: 27270109
Nat Genet. 2015 Sep;47(9):987-995
pubmed: 26237428
J Invest Dermatol. 2016 May;136(5):930-937
pubmed: 26829030
Nat Genet. 2009 Aug;41(8):920-5
pubmed: 19578364
Nat Commun. 2016 Aug 19;7:12510
pubmed: 27539887
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Curr Opin Oncol. 1997 Jan;9(1):88-93
pubmed: 9090499
Med J Aust. 2017 Oct 16;207(8):339-343
pubmed: 29020905
Nat Commun. 2016 Jul 18;7:12048
pubmed: 27424798
Nat Genet. 2018 Feb;50(2):229-237
pubmed: 29292387
Cancer Discov. 2016 Jun;6(6):584-93
pubmed: 27029895
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Front Oncol. 2018 Mar 28;8:86
pubmed: 29644214
Cancer Epidemiol Biomarkers Prev. 2016 Apr;25(4):714-20
pubmed: 26908436
Nat Genet. 2015 Aug;47(8):856-60
pubmed: 26121088
Hum Mol Genet. 2011 Sep 15;20(18):3718-24
pubmed: 21700618
Nat Methods. 2011 Dec 04;9(2):179-81
pubmed: 22138821
Healthcare (Basel). 2017 Nov 01;5(4):
pubmed: 29104226
Am J Prev Med. 2015 Feb;48(2):183-187
pubmed: 25442229

Auteurs

Upekha E Liyanage (UE)

Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia.

Matthew H Law (MH)

Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia.

Xikun Han (X)

Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia.

Jiyuan An (J)

Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia.

Jue-Sheng Ong (JS)

Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia.

Puya Gharahkhani (P)

Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia.

Scott Gordon (S)

Genetic Epidemiology, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia.

Rachel E Neale (RE)

Cancer Aetiology and Prevention, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia.

Catherine M Olsen (CM)

Cancer Control Group, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia.
Faculty of Medicine, The University of Queensland, Brisbane, QLD 4006, Australia.

Stuart MacGregor (S)

Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia.

David C Whiteman (DC)

Cancer Control Group, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD 4006, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH